Fenton Mary Kay 4
4 · Cullinan Therapeutics, Inc. · Filed Apr 30, 2024
Insider Transaction Report
Form 4
Fenton Mary Kay
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-04-29+200,000→ 200,000 totalExercise: $27.12Exp: 2034-04-29→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 200,000 shares of the Issuer's Common Stock, 25% of which will become vested and exercisable on April 29, 2025, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.